Altimmune Announces Proposed Underwritten Public Offering of Securities [Yahoo! Finance]
Barclays PLC (BCS)
US:NYSE Investor Relations:
home.barclays/barclays-investor-relations.html
Company Research
Source: Yahoo! Finance
company developing pemvidutide to address serious liver diseases, today announced it has commenced an underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase an equivalent number of shares of its common stock (or pre-funded warrants in lieu thereof), and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying common stock warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof). All of the shares, pre-funded warrants and accompanying common stock warrants to be sold in the proposed public offering are being offered by Altimmune. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed public offering may be completed or as to the actual terms of the offering. Altimmune intends to use the net proceeds from this proposed offering to fund its upcoming Phase
Show less
Read more
Impact Snapshot
Event Time:
BCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCS alerts
High impacting Barclays PLC news events
Weekly update
A roundup of the hottest topics
BCS
News
- Barclays (BCS) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b)" to "buy (b-)".MarketBeat
- Securities Fraud Investigation Into Barclays PLC (BCS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire
- Barclays PLC (BCS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire
- Securities Fraud Investigation Into Barclays PLC (BCS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire
- Why Atlassian Stock Stumbled Today [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
BCS
Sec Filings
- 4/13/26 - Form 6-K
- 4/7/26 - Form 6-K
- 4/1/26 - Form 6-K
- BCS's page on the SEC website